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ABSTRACT: Intraneuronal accumulation of amyloid-β (Aβ) is an early
pathological signum of Alzheimer’s disease, and compartments of the
endolysosomal system have been implicated in both seeding and cell−cell
propagation of Aβ aggregation. We have studied how clathrin-independent
mechanisms contribute to Aβ endocytosis, exploring pathways that are
sensitive to changes in membrane tension and the regulation of Rho
GTPases. Using live cell confocal microscopy and flow cytometry, we show
the uptake of monomeric Aβ(1-42) into endocytic vesicles and vacuole-like
dilations, following relaxation of osmotic pressure-induced cell membrane
tension. This indicates Aβ(1-42) uptake via clathrin independent carriers
(CLICs), although overexpression of the bar-domain protein GRAF1, a key
regulator of CLICs, had no apparent effect. We furthermore report reduced Aβ(1-42) uptake following overexpression of
constitutively active forms of the Rho GTPases Cdc42 and RhoA, whereas modulation of Rac1, which is linked to macropinosome
formation, had no effect. Our results confirm that uptake of Aβ(1-42) is clathrin- and dynamin-independent and point to the
involvement of a new and distinct clathrin-independent endocytic mechanism which is similar to uptake via CLICs or
macropinocytosis but that also appear to involve yet uncharacterized molecular players.
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■ INTRODUCTION
Alzheimer’s disease (AD) is characterized by the aggregation of
amyloid-β (Aβ) peptides resulting in the formation of
extracellular plaque deposits in the brain1,2 alongside the
formation of intracellular neurofibrillary tau tangles.3 Aβ has
been suggested as a causative agent of AD pathology;4 many
familial forms of AD are associated with mutations that
enhance the aggregation propensity of Aβ or alter, disfavorably,
its production, processing, and clearance.5−9 Aβ is formed by
proteolytic cleavage of the amyloid precursor protein (APP).10
This predominantly occurs in endolysosomal organelles
whereupon Aβ can be secreted or retained.11 Extracellular
Aβ can efficiently enter cultured cells via endocytosis.12−15 It
reportedly also enters neurons following tail vein injections
into mice with a compromised blood brain barrier,16
suggesting that the intra- and extracellular Aβ pools are
dynamically related.17 The confinement of Aβ in endolysoso-
mal vesicles subjects the peptide to aggregation promoting
conditions, including low pH18 and the presence of lipid
membranes.19 Accordingly, we and others have shown that
endocytosed Aβ is aggregating inside living cells,14,20 and it has
been suggested that endolysosomal compartments could serve
as initial sites of Aβ seed formation.15,21 Interestingly, in this
regard, intraneuronal buildup of Aβ appear as one of the
earliest signs of AD, typically manifesting before the formation
of extracellular plaques.22−24 For these reasons, as well as the
putative importance of endocytosis and the endolysosomal
system in the prion-like cell-cell propagation of Aβ
aggregation,25,26 it is important to better understand how Aβ
peptides are endocytosed and accumulated.
We have previously shown that both Aβ(1-40) and Aβ(1-
42) (the two most commonly occurring Aβ isoforms11) are
taken up via clathrin- and dynamin-independent endocytosis
when applied to cultured cells in monomeric form;13 this
uptake was furthermore perturbed by actin depolymerization
and pharmacological inhibitors of macropinocytosis. We and
others have also demonstrated an important role for cell
surface proteoglycans.20,27−29 In this study, we further explore
Aβ uptake, focusing on clathrin-independent endocytosis
(CIE) mechanisms. We also explore the regulatory role of
small signaling G-proteins of the Rho GTPase family, due to
their key role in regulating actin dynamics during CIE30 and
their putative function as target molecules in AD patho-
genesis.31
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While the mechanisms and functions of clathrin-mediated
endocytosis (CME) have been well studied in many
physiological contexts,32 CIE mechanisms remain much less
well-defined due to their diversity and complexity.33 It is not
yet understood how many distinct CIE mechanisms a cell
actually has nor is it clear how extensively these paths are used
in different cell types. Reports range from almost exclusive use
of CME,34 to situations where the majority of the cellular
endocytic volume is internalized via CIE.35 CIE is, importantly,
active in neurons, contributing to cargo uptake and fast
regulation of membrane turnover at synapses36 where Aβ
peptides are also present. In addition to the implicated role in
Aβ monomer uptake,13,20 CIE also contributes to the neuronal
internalization of the APP-processing enzyme BACE1,37 the
amyloidogenic human PrP protein,38 as well as several types of
amyloid oligomers and fibrils.39,40
The molecular and mechanistic classification of CIE has
been complicated by the apparent lack of specific cargoes and
exclusive regulators.33 Nonetheless, at least three distinct
pathways exist, all regulated by activating/deactivating cycling
of specific small signaling G-proteins of the Rho GTPase
family30,41 (Figure 1). Macropinocytosis is initiated by large
(micrometer size-range), actin-driven membrane protrusions
and is activated by specific signals,42 such as growth factors,
chemokines,43 cationic peptides,44 and amyloid assemblies.39
Rac1 activation is highly coupled to macropinocytosis.30 Fast
endophilin-mediated endocytosis (FEME)45 results from cargo
capture and local membrane bending assisted by the
endophilin BAR-domain and other cytosolic proteins.41
FEME is important in assisting fast membrane recycling at
the synapse46 and occurs under the regulatory control of
dynamin as well as the Rho GTPases Rac1 and RhoA. It is
furthermore activated upon inhibition of Cdc42.45 The
dynamin independence of Aβ endocytosis13 suggests, however,
that FEME is not involved; notably this was further reinforced
by our study. Finally, CIE uptake can also occur via clathrin-
independent carriers (CLICs) into glycosylphosphatidylinosi-
tol (GPI)-anchored protein enriched endocytic compartments
(GEECs; CLIC/GEEC).47,48 CLIC/GEEC is a constitutive
and cargo clustering driven pathway important for the uptake
of GPI-anchored proteins, glycosylated cargoes, certain toxins,
and glycosphingolipids.41 CLICs are furthermore involved in
the endocytosis of the brain abundant lipid GM1, which is a
well-recognized Aβ binding partner.49 CLIC formation is
regulated by Cdc42, and the formation of at least one
subpopulation of CLICs is also dependent on the GTPase-
regulatory and BAR-domain containing protein GRAF1.47,50,51
Endocytosis via CLIC/GEEC, but also via macropinocytosis,
is modulated by changes in plasma membrane tension,52−54
and the mechanisms are upregulated under conditions where
cells need to rapidly internalize excess plasma membrane.
Their involvement in cargo uptake can therefore be explored
by altering the tonicity of the cell culture medium51,53,54 as
explored here.
The small Rho GTPases in this study are not only important
regulators of CIE, they are also involved in both neuronal
development and neurodegeneration, and their activity
(specifically that of Rac1 and RhoA) has been observed to
decrease in the brains of patients with AD.55 Furthermore,
Rac1 activation increases the production of Aβ from APP and
results in hyperphosphorylation of tau, thereby providing a
possible link between these two AD-relevant pathological
hallmarks.56 It has also been suggested that soluble Aβ(1-40)
peptides can reduce neurite length in a neuroblastoma model
by inducing RhoA activity,57 whereas application of fibrillar
Aβ(1-42) to neurons has been reported to result in
dysregulated actin polymerization through altered activity of
Rac1 and Cdc42.58 Furthermore, Aβ(1-42) oligomers have
been observed to exert cellular toxicity in a RhoA-dependent
manner, following internalization.59 By being key regulators of
several AD-related signals, Rho GTPases have also been
suggested as possible therapeutic targets.60 Thus, effects of Aβ
internalization on Rho GTPase regulation have been
established in several AD-relevant contexts, but it has not yet
been explored how modulation of various Rho GTPases per se
affect the clathrin-independent endocytic uptake of Aβ itself.
Lastly, several reports link AD to dysregulated cholesterol
metabolism,61 and it has been shown in a variety of in vitro
biophysical contexts that amyloid assemblies, including Aβ, are
in themselves potent modulators of membrane organization,
integrity, and bending,62 suggesting they might have direct,
cargo-mediated effects on various types of CIE.
This study extends our previous work on Aβ endocytosis by
focusing specifically on the role of CIE in the uptake of Aβ(1-
42) monomers. We probe CIE mechanisms by modulating cell
membrane tension,52 Rho GTPase expression (Cdc42, Rac1
and RhoA), and the activity of the CLIC/GEEC specific
GTPase activating protein GRAF1.50 We show that the uptake
of Aβ(1-42), supplied to human neuroblastoma SH-SY5Y cells,
is catalyzed upon relief of hypotonic media-induced plasma
membrane tension via a mechanism that is under regulatory
control of the small GTPases Cdc42 and RhoA but not Rac1.
These findings suggest that actin polymerization is highly
important but that internalization is not via macropinocytosis
in its most classical description. Furthermore, Aβ(1-42),
despite being previously shown to occur at the leading edge
of cells and in areas of high membrane ruffling, was found to be
independent of GRAF1, suggesting that its CIE uptake involve
other, yet unidentified, endocytic membrane sculpting
proteins. Altogether, this work has revealed new insights into
how components of CIE are related to the endocytosis of
Aβ(1-42) and, significantly, pointed out that AD-relevant
dysregulations of Rho GTPase activities could importantly
influence the extent of intraneuronal Aβ accumulation.
Figure 1. Clathrin-independent endocytosis (CIE). Uptake via the
CIE paths macropinocytosis, FEME, and CLIC/GEEC, highlighting
the respective involvement of the Rho GTPases Cdc42, Rac1 and
RhoA, as well as that of GRAF1 and sensitivity to changes in
membrane tension.
ACS Chemical Neuroscience pubs.acs.org/chemneuro Research Article
https://dx.doi.org/10.1021/acschemneuro.0c00053
ACS Chem. Neurosci. 2020, 11, 1925−1936
1926
■ RESULTS AND DISCUSSION
Cellular Uptake of Monomeric Aβ(1-42) Is Increased
by the Alleviation of Hypotonic-Media Induced Mem-
brane Tension. Uptake into endolysosomal compartments
and subsequent intraneuronal accumulation have been
implicated in both seeding and cell−cell propagation of
Aβ(1-42). Previous work has shown that uptake of monomeric
Aβ(1-42) is clathrin-independent,13 and in order to further
map out the involved endocytic paths and regulators, we here
focus on clathrin-independent endocytosis (CIE).
First, we explored how modulation of the plasma membrane
tension, achieved by altering the tonicity of the incubation
medium,63−65 influenced the cellular uptake of Aβ(1-42),
applied in highly monomeric form, to cultured SH-SY5Y
neuroblastoma cells. Such acute changes in membrane tension
have previously been described in studies on CLIC/GEEC in
HeLa cells51,54 and is an approach to mimic the dynamic
changes in membrane tension that occur at cell membrane
protusions.54,66 In previous studies, uptake via CLIC/GEEC
was found to be upregulated following the sudden reduction in
membrane tension that occur when cells are transferred from
hypotonic medium to isotonic medium.51,54 A recent study
using mouse-derived myoblasts suggests that also macro-
pinocytosis can be affected by these conditions;53 hence,
exposing cells to a sudden reduction in membrane tension is an
approach to probe for uptake via the CLIC/GEEC pathway
and/or macropinocytosis.
In our experiments, cells were sequentially subjected to
isotonic (cell culture medium), hypotonic (25% cell culture
medium, 75% MQ water) and recovery (transfer from
hypotonic to cell culture medium) conditions for 10 min
each while simultaneously being exposed to highly monomeric
preparations13 of fluorescently labeled (HiLyteFluor488
(HF488)) Aβ(1-42) peptides and the fluid phase marker
dextran 10 kDa (labeled with AlexaFluor647 (AF647)). Cells
were imaged by time lapse confocal microscopy (Supple-
mentary Movies 1−3) after washing away external, non-
internalized peptide and dextran at the end of each 10 min
incubation period (Figure 2A). Under isotonic conditions, the
formation of small endosomal vesicles containing Aβ(1-42)
was observed (Supplementary Movie 1 and Figure 2A, top
row), consistent with previous reports by us and others.12−15
The fluorescence intensities in the movies and images are
weak, due to the short incubation period and low Aβ(1-42)
concentration (2 μM); also the uptake of dextran, which is a
nonspecific fluid phase endocytosis marker,67 is low. During
exposure to hypotonic conditions, the cells expanded and
rolled up due to an osmotic pressure-induced increase in cell
volume. Previous studies have shown that this is accompanied
by an increase in plasma membrane tension,63−65 which was
increased by a factor of 3 (from 0.04 to 0.12 mN/m) in
molluscan neurons exposed to hypotonic medium (50%
MQ).64 In our experiments, we observe little or no
internalization of Aβ(1-42) and dextran (Supplementary
Movie 2 and Figure 2A, middle row). During re-exposure to
isotonic conditions (recovery), the cells readopted normal
morphology and resumed to internalize Aβ(1-42) (Figure 2A,
bottom row) into both smaller endosomal vesicles and larger
structures. The latter are consistent in appearance with the
vacuole-like dilations (VLDs) that have been reported during
similar membrane tension changing conditions in other
studies,52,68 including those using neurons.69,70 Uptake of the
CME-ligand71 transferrin (Trf) was blocked under hypotonic
treatment and remained low throughout the recovery period
(Supplementary Figure S1), demonstrating that CME is not
upregulated upon a reduction in membrane tension in SH-
SY5Y cells, in agreement with a previous study using CHO
cells.52 Uptake of dextran was also induced by recovery from
Figure 2. Cellular uptake of Aβ(1-42) in cells exposed to a hypotonic shock. (A) Confocal microscopy images of SH-SY5Y cells incubated with 2
μM HF488-labeled Aβ(1-42) and 250 μg/mL AF647-labeled dextran 10 kDa for 10 min during either isotonic or hypotonic (75% MQ water, 25%
cell culture medium) conditions. Recovery denotes cells transferred back to isotonic media after the 10 min hypotonic treatment, at which point
Aβ(1-42) and dextran was also added. The scale bars in part A represent 20 μm. The isotonic/hypotonic/recovery images have been acquired with
identical settings and post-treated in the same manner, i.e., the displayed intensities are comparable for Aβ(1-42) and dextran, respectively. Inserts
display zoomed areas. (B) Zoomed images of one representative cell with AF647-labeled dextran 10 kDa-filled VLDs (internalized during exposure
to 250 μg/mL dextran for 10 min at recovery conditions). The time-lapse was started after the 10 min recovery period and a 1× wash, and the cells
were imaged by confocal microscopy. The scale bar is 5 μm. The time lapse movie is displayed as Supplementary Movie 4.
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the hypotonic treatment (Figure 2A, bottom row). Contrasting
to Aβ(1-42), this fluid-phase marker only appeared to
internalize into VLDs (Supplementary Movie 3), indicating a
behavioral difference and a higher degree of specificity of
Aβ(1-42) towards small vesicles. The small Aβ(1-42)
containing endosomes could either originate from a specific
upregulation of a distinctive endocytic pathway or from a
specific type of uptake from the VLDs as such. We therefore
monitored the faith of the dextran-containing VLDs in the SH-
SY5Y cells by time lapse microscopy (Figure 2B, Supple-
mentary Movie 4; recordings started when the cells had been
kept for 10 min in the recovery phase), observing both
tubulation and concurrent fission of the tubules. This confirms
that the VLDs are internal and dynamic structures that are
being degraded and eventually eliminated by the cell.54 An
interesting observation in this regard is that the VLDs we
observe in SH-SY5Y cells persist longer (in general >10 min),
compared to VLDs in HeLa or mouse embryonic fibroblasts
cells (where they disappear within minutes);54,68 the number
of VLDs per SH-SY5Y cell also appears to be high. It is
possible that these differences stem from the fact that SH-
SY5Y cells, like all neuroblastoma cells, lack caveolin-172 and
therefore cannot regulate their cell surface in response to
membrane tension reduction by caveolae formation.33,41 We
also characterized the response of SH-SY5Y cells to the acute
changes in membrane tension applied in our experiments by
imaging the actin cytoskeleton in cells transfected with
CellLight Actin-GFP (Supplementary Movie 5 and Figure
S2). While actin filaments were clearly visible in cells before
the hypotonic treatment, these structures rapidly disassembled
following addition of MQ, in agreement with previous
reports.63,73 Furthermore, within the timespan of the recovery
experiment, the actin filaments did not completely re-establish;
instead more punctate filaments were formed.
To quantitate how changes in membrane tension affected
cell uptake of Aβ(1-42), Trf, and dextran, we used flow
cytometry. Figure 3A shows mean fluorescence intensities
(normalized relative to uptake in isotonic media), supporting
the imaging data (Figure 2A and Supplementary Figure S1).
Interestingly, the extent of Aβ(1-42) uptake during the
recovery phase merely doubles, whereas the uptake of dextran
is increased ∼8 times, suggesting a difference in uptake
mechanism and membrane tension dependence of the two
macromolecules. This was further substantiated by the
observation that the uptake of Aβ(1-42) and dextran during
recovery has different linear concentration dependence (Figure
3B, Supplementary Figure S3); the concentration dependence
for Aβ(1-42) has a slope of 4.3 ± 0.7 compared to 13.5 ± 2.1
for dextran).
We next explored how the uptake of Aβ(1-42) and dextran
during recovery depended on the magnitude of the hypotonic
shock, probing also smaller changes in membrane tension
(Figure 3C,D). Aβ(1-42) and dextran have very similar trends,
and clear effects are only observed above 50% MQ, which has
also been applied in other studies.51,54 Exposure of the cells to
hypertonic media (addition of 100 mM NaCl to the culture
medium) to reduce membrane tension did not increase Aβ(1-
42) or dextran uptake (Supplementary Figure S4), suggesting
that uptake during membrane tension reduction is directly
related to the cell’s need to reduce its cell membrane surface
area.
Cellular Uptake of Aβ(1-42) Is Independent of GRAF1.
Building on the results above, demonstrating a membrane
tension-sensitive endocytosis of Aβ(1-42), we next explored if
the uptake was mediated via GRAF1-dependent CLIC/GEEC.
We used an engineered HeLa Flp-In T-REx cell line with an
inducible expression of GFP-GRAF1,54 but it has also been
shown that GRAF1 is constitutively expressed and thus
relevant for CIE in SH-SY5Y cells.50 The HeLa cell line was
transfected with mCherry-tagged Cdc42 (WT and dominant
active (DA) Q61L mutant). Upon doxycycline-induced low
level expression of GFP-GRAF1, punctuate and tubular
GRAF1-positive structures appeared in cells expressing DA
Cdc42 Q61L but not Cdc42 WT, as reported by Vidal-
Quadras et al.54 CLIC/GEEC ligands are expected to be
trapped in these GRAF1-structures but unable to transit
further due to the DA Cdc42 Q61L overexpression, thus
enabling visualization of GRAF1-mediated uptake via CLIC/
GEEC, which is otherwise a very fast event.35 Cells were
incubated with 1 μM Aβ(1-42) for 40 min, resulting in the
formation of Aβ(1-42)-containing endosomal vesicles that did
not colocalize with, or appear to display any similar
intracellular distribution pattern as, GRAF1 in cells transfected
with Cdc42 Q61L (Figure 4A). Since it is possible that the lack
of colocalization between Aβ(1-42) and GRAF1 is due to the
fairly long incubation time (40 min; needed to achieve high
signal-to-noise images of intracellular Aβ(1-42) in this case), it
cannot be excluded that Aβ(1-42) has been trafficked from
CLICs to downstream endosomal organelles by the time of
analysis. Therefore, we also exposed cells to a shorter
incubation pulse (15 min) at a higher peptide concentration
Figure 3. Cellular uptake of Aβ(1-42) is influenced by changes in
membrane tension. (A) Quantification of cellular uptake of 2 μM
HF488-labeled Aβ(1-42), 250 μg/mL AF647-labeled dextran 10 kDa
or 5 μg/mL AF488-labeled transferrin (Trf) during 10 min isotonic,
hypotonic (75% MQ) and recovery conditions, as explained in Figure
2A. N = 8 (Aβ(1-42) and dextran) or N = 4 (Trf), n = 3−4. (B)
Cellular uptake as a function of concentration of HF488-labeled
Aβ(1-42) and AF647-labeled dextran, monitored during the 10 min
recovery period after an hypotonic shock (75% MQ), as explained in
Figure 2A, n = 4. (C,D) Cellular uptake of (C) HF488-labeled Aβ(1-
42) and (D) AF647-labeled dextran in cells exposed to a hypotonic
shock following the same experimental procedure as in part A but
with varying content of MQ in the hypotonic medium (N = 3−4, n =
3−4). (A−D) Cells were analyzed by flow cytometry, and uptake is
reported as mean cellular uptake relative to uptake in cells exposed to
isotonic conditions.
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(5 μM) (Supplementary Figure S5), but we still did not
observe colocalization. We also imaged GFP-GRAF1 and
mCherry-Cdc42-Q61L positive cells by time-lapse microscopy
with simultaneous detection of GRAF1 and Aβ(1-42) using a
filter cube to split the signals (see snap-shots in Figure 4B and
Supporting Movie 6). No apparent comovement of GRAF1-
and Aβ(1-42)-containing vesicles was observed. Furthermore,
GRAF1-positive vesicles appeared to be quite immobile
compared to the Aβ(1-42)-containing endosomes, which
moved rapidly. The conclusion is therefore that GRAF1 is
not a mediator of Aβ(1-42) uptake. However, since the
understanding of CLICs is not complete, it is still possible that
Aβ(1-42) internalizes via this route, albeit under the regulation
of alternative yet unidentified membrane sculpting proteins.
Involvement of Rho GTPases Cdc42, Rac1, and RhoA
in Endocytosis of Aβ(1-42). Rho GTPases are important
regulators of CIE (Figure 1).30,41 When studying the role of
GRAF1 in Aβ(1-42) uptake, we observed differences in the
intensity and number of Aβ(1-42)-positive fluorescent foci in
HeLa cells overexpressing WT and dominant active (Q61L)
Cdc42 (Figure 4A), suggesting that this small Rho GTPase
modulates uptake. Since Cdc42 (and other Rho GTPases)
regulate the actin cytoskeleton,74 this would be consistent with
our previously published result that inhibitors of actin
polymerization reduced Aβ(1-40) and Aβ(1-42) but not Trf
internalization in SH-SY5Y cells.13 To follow up on this
finding, we explored systematically how Aβ(1-42) uptake
depends on overexpression of WT, DN, and DA forms of
Cdc42 as well as Rac1 and RhoA, which are two additional
well-described Rho GTPases that furthermore have been
implicated in AD pathology31 and to some extent appear to be
regulated by the presence of Aβ peptides.57,58
First, cells were transfected with EGFP-Cdc42 variants (WT,
DN, DA), followed by 1 h treatment with 1 μM Aβ(1-42)
(Figure 5A) or 5 min with 5 μg/mL Trf (Supplementary
Figure S6). The EGFP-Cdc42 expressing cells have altered
morphologies, with increased filopodia formation, consistent
with the effect of Cdc42 on the actin skeleton.74 Furthermore,
the cell-to-cell variation in EGFP intensity shows that
transfected cells expressed different amounts of the EGFP-
Cdc42 variants, as confirmed by flow cytometry (Figure 5B).
We took advantage of this when quantifying Aβ(1-42) and Trf
uptake, by gating cells as nontransfected (overlapping with the
intensity of mock cells transfected with MQ water, see
Supplementary Figure S7) and low, medium, and high
transfected (Figure 5B) based on their EGFP intensity, as
previously described.13 Within each gate, we determined the
mean cellular fluorescence intensity of HF647-labeled Aβ(1-
42) or AF647-labeled Trf (Figure 5C), allowing observation of
concentration-dependent effects. We found that both Aβ(1-
42) and Trf uptake is reduced by overexpression of DA EGFP-
Cdc42 Q61L, suggesting that Cdc42 modulation can effect
both CIE and CME. Control experiments showed that the
uptake of dextran was unaffected (Supplementary Figure S8),
confirming no effect on the intrinsic endocytic capacity of the
cells. Overexpression of WT or DN EGFP-Cdc42 had no effect
on Aβ(1-42) and Trf uptake (Figure 5C).
We repeated this set of experiments, exploring also the Rho
GTPases Rac1 and RhoA. Overexpression of EGFP-tagged
Rac1 (DA Q61L, WT, and DN T17N) induced lamellipodia-
like morphologies in transfected cells as expected from the
literature.74 None of the Rac1 variants had any effect on Aβ(1-
42) uptake (Figure 6A,B), not even at the highest levels of
overexpression (see Supplementary Figure S10 for depiction of
the flow cytometry gates), although a reduction of Trf uptake
Figure 4. Uptake of Aβ(1-42) is independent of GRAF1 in HeLa cells. (A) HeLa Flp-In T-REx cells were induced to express GFP-tagged GRAF1
after transfection with either WT Cdc42 or DA Cdc42 Q61, both mCherry-tagged. The cells were incubated with 1 μM HF647-labeled Aβ(1-42)
for 40 min, washed, and imaged by confocal microscopy. GRAF1 forms both punctate and tubular structures in cells expressing Cdc42 Q61L.
Aβ(1-42) is not found to colocalize with these. The scale bars represent 20 μm. (B) Cells transfected with Cdc42 Q61L as in part A but exposed to
a 15 min pulse of 5 μM Aβ(1-42) followed by time-lapse imaging by confocal microscopy. The whole-cell image (large image) shows the zoomed
area (Cdc42 expression pattern depicted in Supplementary Figure S5), and small images are from the time lapse in Supplementary Movie 6. The
scale bar is 20 μm in the whole-cell image and 2 μm in the zoomed-in images.
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in the cells with the highest concentration of WT and DN
Rac1 was observed. The latter result is contrasting observations
by Lamaze et al.,75 investigating Trf uptake in HeLa cells,
highlighting how highly variable endocytic responses can be
among cell types. We also observe that cells with a “medium”
expression level of DA Rac1 appear to internalize slightly more
Trf than control, suggesting that endocytic pathways may be
sensitively fine-tuned by the transient concentration of
adaptors. Modulation of Rac1 did not alter the endocytic
capacity of cells, as measured by the uptake of dextran
(Supplementary Figure S8). Considering the involvement of
Cdc42 and Rac1 in macropinocytosis,30 which we have
previously inhibited by IPA-3 and wortmannin showing
reductions in the uptake of Aβ(1-40) and Aβ(1-42),13 it is
noteworthy that we do not observe any effects on Aβ(1-42)
uptake with Rac1. This is furthermore interesting in relation to
a study showing that the uptake of fibrillar Aβ(1-42) by
microglia depends on Rac1.76 This points to differences in the
uptake mechanisms of soluble and fibrillar Aβ forms. We have
recently observed similar, seemingly mechanistic differences in
the uptake of preformed fibril fragments and monomers of the
Parkinson’s disease related protein α-synuclein.40
Lastly, cells were transfected with EGFP-tagged RhoA (DA
Q63L, WT, and DN T19N) and exposed to Aβ(1-42) and Trf,
followed by analysis by confocal microscopy (Aβ(1-42) in
Figure 7A, Trf in Supplementary Figure S11) and flow
cytometry (Figure 7B, gates in Supplementary Figure S12).
This showed that the uptake of both Aβ(1-42) and Trf is
reduced following overexpression of all variants of RhoA. The
most extensive concentration-dependent effect is seen with DA
Q63L, but statistically significant reductions in uptake were
also observed following overexpression of WT and T19N
(T19N; high transfection gate not included due to too few
cells). The uptake reduction in cells expressing DA RhoA
could, at least partially, be explained by an overall decrease in
endocytic activity as the uptake of dextran 10 kDa is reduced
by up to 50% (Supplementary Figure S8). However, reports by
Yu et al.59 demonstrate involvement of RhoA in endocytosis of
Aβ(1-42) oligomers, in-line with our results. Also, the results
do not point toward any importance of fast endophilin-
Figure 5. Cellular uptake of Aβ(1-42) is reduced by Cdc42 Q61L overexpression. (A) Confocal microscopy images of SH-SY5Y cells transfected
with EGFP-tagged Cdc42 (DA Q61L, WT, or DN T17N) following incubation with 1 μMHF647-labeled Aβ(1-42) for 1 h. The scale bar is 20 μm
and representative for all images. The asterisks (*) marks the positions of cells that are not expressing Cdc42. (B) Representative flow cytometry
histograms (cell count vs intensity) of cells analyzed 24 h post transfection with EGFP-labeled Cdc42. For further analysis, the cells were gated for
peptide uptake based on transfection efficiency and the extent of EGFP-Cdc42 overexpression (e.g., green fluorescence; none, low, medium, and
high) as indicated in the figures. (C) Quantification of Aβ(1-42) and Trf uptake in cells transfected with Cdc42. The cells were incubated with
either 1 μM HF647-labeled Aβ(1-42) for 1 h or 5 μg/mL AF647-labeled Trf for 5 min, washed, and analyzed for intracellular peptide signal by flow
cytometry. Uptake is reported as relative mean cellular fluorescence in relation to uptake in nontransfected cells (N = 3, n = 4). Asterisk (*) marks
uptake levels that are significantly different from uptake in nontransfected cells (adjusted p-value <0.05) by one-way ANOVA with matched data
followed by multiple comparisons with Bonferroni posthoc test (adjusted p-values were Q61L, Aβ(1-42) none vs high 0.0001 and Trf none vs high
<0.0001).
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mediated endocytosis (FEME)45 in Aβ(1-42) internalization,
as the uptake levels after perturbation of Rho GTPase activity
are different compared to what would be expected if FEME
(which is sensitive to perturbation of Rac1 and RhoA but
activated upon Cdc42 inhibition45) was involved. This finding
is also in-line with the dynamin-dependent nature of FEME
and the demonstrated lack of involvement of dynamin in
monomeric Aβ endocytosis.
■ CONCLUSION
In this study, we have used live cell confocal fluorescence
microscopy and flow cytometry to study how perturbation of
endocytic mechanisms that are sensitive to changes in
membrane tension and the regulatory control of Rho GTPases
influence the cellular uptake of monomeric Aβ(1-42). This
extends previous work by us and others in this area and
provides additional insight into cell biological mechanisms and
pathways that contribute to the Alzheimer’s disease relevant
endolysosomal accumulations of Aβ(1-42).
We report that Aβ(1-42) uptake into SH-SY5Y cells is
sensitive to osmotic pressure-induced alterations in membrane
tension, which points to the involvement of CLICs or
macropinocytosis. Importantly, Aβ(1-42) behaves distinctively
different than the CME-cargo Trf, but also dextran, which is an
unspecific fluid-phase endocytosis marker. This suggests that
Aβ(1-42) uptake occurs by a specific and differently regulated
uptake path. We have previously demonstrated that Aβ(1-42)
uptake is sensitive to perturbations of actin,13 which appears
highly consistent with the findings here on the important
regulatory roles of key CIE regulatory Rho GTPases. In
previous work, we also observed reductions in Aβ(1-42)
uptake upon pharmacological macropinocytosis inhibition.13
Our observations of sensitivity to Cdc42 activity reinforce the
putative importance of this path, although the lack of
sensitivity to Rac1, an activator of the formation of the large
membrane protrusions that drive the formation of macro-
pinosomes,30 suggests that macropinocytotic Aβ(1-42) uptake
may be of a nonclassical type. The sensitivity to reduction of
membrane tension could support macropinocytosis53 but is
mainly consistent with uptake via constitutively active CLIC/
GEEC.52 Importantly, we have previously observed polarized
internalization of Aβ(1-42) in CHO cells, resulting from
lamellipodia,20 which are CLIC-enriched areas.35 Furthermore,
CLICs are important regulators of the cell uptake of the brain-
abundant and AD-relevant glycosphingolipid GM1, which
could be a putative receptor due to its reported tight binding to
Aβ peptides,41,49 influencing also their aggregation77 and
toxicity.78 Notably, we have observed that NIH-3T3 fibroblasts
internalize more Aβ(1-42) than CHO and SH-SY5Y,
consistent with their inherent endocytic capacities.13 We
here note that fibroblasts, in particular, have an exceptionally
high constitutive activation of CLICs.35 Interestingly, in this
regard, we find that Aβ(1-42) uptake is independent of the
BAR domain containing and membrane sculpting protein
GRAF1, which has been put forward as a key regulator of
CLIC formation.50,51
Altogether, we report that Aβ(1-42) internalizes into cells
via a specific and distinctive CIE mechanism that is highly
sensitive to changes in membrane tension and the regulatory
Figure 6. Cellular uptake of Aβ(1-42) is not sensitive to changes in Rac1 expression. (A) SH-SY5Y cells transfected with EGFP-tagged Rac1 (DA
Q61L, WT, or DN T17N) and incubated with 1 μM HF647-labeled Aβ(1-42) for 1 h imaged by confocal microscopy. The scale bar is 20 μm. The
asterisks (*) marks an example of a cell that is not expressing Rac1. (B) Quantification of Aβ(1-42) and Trf uptake in cells transfected with Rac1.
The cells were incubated with either 1 μM HF647-labeled Aβ(1-42) or 5 μg/mL AF488-labeled Trf for 1 h or 5 min, respectively, washed and
analyzed for intracellular peptide signal by flow cytometry. Uptake is reported as relative mean cellular fluorescence and based on level of Rac1-
expression (none, low, medium, and high) in relation to uptake in nontransfected cells (N = 3, n = 4). The gates applied are displayed in
Supplementary Figure S10. The asterisk (*) marks uptake levels that are significantly different from uptake in nontransfected cells (adjusted p-value
<0.05) by one-way ANOVA with matched data followed by multiple comparisons with Bonferroni posthoc test (adjusted p-values were Q61L, Trf
none vs medium 0.0355; WT, Trf none vs high 0.0001; T17N, Trf none vs high <0.0001).
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control of small Rho GTPases. The uptake mechanism appears
similar to uptake via CLICs or possibly macropinocytosis, but
the independence of Rac1 and GRAF1 suggests that it also
involves yet uncharacterized membrane-sculpting and vesicle
coating proteins of these incompletely characterized clathrin-
independent endocytic paths. Better insights into this
molecular machinery, guided by the results presented here,
will undoubtedly provide a clearer cellular and molecular
understanding of how uptake relates to endolysosomal
intraneuronal Aβ accumulation. Putatively, this could also
have important implications toward the development of future
Aβ-clearing therapies, possibly targeting the endocytic path.
■ METHODS
Reagents. Synthetic Aβ(1-42) peptide, conjugated to the HiLyte
Fluor HF488 or HF647 at the N-terminus, were from Anaspec Inc.
(Fremont). The peptide purity was >95% as determined by Anaspec
Inc. by MS and RP-HPLC. AlexaFluor488 (AF488)- and Alexa-
Fluor647 (AF647)-labeled Transferrin (Trf) and AF647-labeled
dextran 10 kDa were from Molecular Probes and purchased via
ThermoFisher Scientific (Gothenburg, Sweden). The human neuro-
blastoma cell line SH-SY5Y was purchased from Sigma-Aldrich, and
the Flp-In T-Rex HeLa cells were from Francis et al.66 Cell culture
reagents (minimal essential medium, nutrient mixture F-12 Ham,
MEM nonessential amino acids, Dulbecco’s Modified Eagles Medium,
heat-inactivated fetal bovine serum, L-glutamine, and trypsin-EDTA
0.25%) and buffers (HEPES and DPBS) were from Gibco or Sigma-
Aldrich, B-27 was from Gibco, and Lipofectamine 2000 was from
Invitrogen and purchased via ThermoFisher Scientific. Doxycycline
hyclate was from Sigma-Aldrich, and hygromycin B from Invitrogen
and blasticidin S HCl from Gibco were both purchased via
ThermoFisher Scientific. Plasmids encoding for EGFP-tagged Rho
GTPases were from Addgene (Cdc42, Q61L no. 12986, WT no.
12975, T17N no. 12976; Rac1, Q61L no. 12981, WT no. 12980,
T17N no. 12982; RhoA, Q63L no. 12968, WT no. 12965, T19N no.
12967), and mCherry-tagged Cdc42 WT and Q61L were from
Francis et al.66
Preparation and Handling of Aβ(1-42). The lyophilized Aβ(1-
42) peptide powders were dissolved in hexafluoro-2-propanol to
disrupt any aggregates79 and monomerize the peptide. The solutions
were vortexed briefly and aliquoted at 4 °C. The solvent in each
aliquot was evaporated at 37 °C for 15 min on a heating block and
additional 45 min using a RVC 2-18 CD rotational vacuum
concentrator (Martin Christ, Germany). The remaining peptide
films were snap frozen in liquid nitrogen and kept at −80 °C until
further use. We have demonstrated that this protocol results in highly
monomeric samples.13 For concentration determinations, the peptide
film was dissolved in 1% ammonium hydroxide (v/v), and the
absorption of the dye label was measured on a Cary 4000 UV−vis
spectrophotometer (Agilent Technologies, Santa Clara, CA).
Extinction coefficients of 70 000 M−1 cm−1 at 504 nm and 250 000
M−1 cm−1 at 649 nm was used for the HF488 and HF647 dye labels,
respectively, according to the information provided by the
manufacturer. Prior to each experiment, one peptide film was
dissolved in a small volume 1% ammonium hydroxide (v/v) and
diluted with cell culture medium supplemented with 2% B-27 and 30
mM HEPES. The concentration of ammonium hydroxide was kept
below 0.01% and was matched in controls to ensure identical
treatment of all samples. Unused samples were discarded in order to
avoid Aβ(1-42) aggregation induced by freeze−thawing.
Figure 7. Cellular uptake of Aβ(1-42) is reduced by RhoA overexpression. (A) SH-SY5Y cells transfected with EGFP-tagged RhoA (DA Q63L,
WT, or DN T19N) and incubated with 1 μM HF647-labeled Aβ(1-42) for 1 h imaged by confocal microscopy. The scale bar is 20 μm. The
asterisks (*) mark an example of a cell that is not expressing RhoA. (B) Quantification of Aβ(1-42) and Trf uptake in cells transfected with RhoA.
The cells were incubated with either 1 μM HF647-labeled Aβ(1-42) or 5 μg/mL AF647-labeled Trf for 1 h or 5 min, respectively, washed and
analyzed for intracellular peptide signal by flow cytometry. Uptake is reported as relative mean cellular fluorescence and based on the level of RhoA-
expression (none, low, medium, and high) in relation to uptake in nontransfected cells (N = 4, n = 4). T19N-transfected cells displayed few cells in
the high transfected-gate, and this data was thus not included. The gates applied are displayed in Supplementary Figure S12. Asterisk (*) marks
uptake levels that are significantly different from uptake in nontransfected cells (adjusted p-value <0.05) by one-way ANOVA with matched data
followed by multiple comparisons with Bonferroni posthoc test (adjusted p-values were Q63L, Aβ(1-42) none vs medium 0.0013, none vs high
<0.0001, Trf none vs medium <0.0001, none vs high <0.0001; WT, Aβ(1-42) none vs high 0.0224, Trf none vs medium 0.0059, none vs high
<0.0001; T19N, Aβ(1-42) none vs medium 0.0098, Trf none vs medium 0.0003).
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Cell Culture and Sample Preparation. Cell Maintenance and
Seeding. SH-SY5Y cells were grown in a 1:1 mixture of minimal
essential medium (MEM) and nutrient mixture F-12 Ham
supplemented with 10% heat-inactivated fetal bovine serum, 1%
MEM nonessential amino acids, and 2 mM L-glutamine. The cells
were detached (trypsin-EDTA 0.25%, 5 min) and passaged twice a
week. Cells were plated 1 day prior to experiments in either flat-
bottomed 96 well plates (Nunc or VWR; 50 000 cells/well) for flow
cytometry or in glass-bottomed culture dishes (MatTek; 25 000 cells
(untreated cells) or 100 000 (transfected cells)/14 mm dish) for
microscopy. Flp-In T-Rex HeLa cells with inducible expression of
GFP-GRAF166 were grown in DMEM supplemented with 10% heat-
inactivated fetal bovine serum, 2% L-glutamine, and with the addition
of 100 μg/mL hygromycin B and 5 μg/mL blasticidin S HCl. The
cells were detached (trypsin-EDTA 0.25%, 3 min) and passaged twice
a week. Transfected cells were plated 1 day prior to experiments in
glass-bottomed culture dishes (MatTek; 50 000 cells/14 mm dish) for
microscopy.
Alterations in Membrane Tension. SH-SY5Y cells were incubated
with Aβ(1-42), Trf, and dextran 10 kDa while exposed to changes in
membrane tension and analyzed by confocal microscopy and flow
cytometry. For uptake at isotonic conditions, the cells were washed
1× with serum-free medium, incubated with either 2 μM HF488-
labeled Aβ(1-42), 5 μg/mL AF488-labeled Trf, or 250 μg/mL AF647-
labeled dextran 10 kDa in serum-free medium with the addition of 2%
B-27 for 10 min, washed 1× with serum free medium for microscopy,
or 3×/2 min on ice with either ice-cold serum-free medium (Aβ(1-
42) and dextran) or acidic buffer (0.1 M glycine-HCl buffer pH 2.5
with 150 mM NaCl; Trf)80 and harvested for analysis by flow
cytometry. For uptake at hypotonic conditions, the cells were first
pretreated for 10 min in isotonic medium where after they were
incubated with the peptides and dextran for 10 min as outlined above
but diluted in hypotonic medium (25−75% MQ water added to the
isotonic medium). Lastly, cells analyzed for uptake at recovery
conditions were first pretreated with isotonic medium for 10 min
followed by treatment in hypotonic medium for 10 min, whereupon
they were exposed to the peptides and dextran in isotonic medium for
10 min.
Transfection of Rho GTPases and Induction of GRAF1
Expression. SH-SY5Y cells were passaged 2 days prior to transfection,
grown to ∼70% confluency, and transfected with plasmids encoding
for Rho GTPases (EGFP-tagged DA, WT, and DN variants of Cdc42,
Rac1, and RhoA; see the above section Reagents) by electroporation
using a Neon Transfection System (Invitrogen, Carlsbad, CA),
following the protocol provided by the manufacturer and applying a
single pulse of 1 100 V with a pulse width of 50 ms. The cells were
transfected using 1 μg of plasmid DNA/100 000 cells in a 10 μL Neon
Tip or 10 μg of plasmid DNA/106 cells in a 100 μL Neon Tip and
plated immediately after. Based on the initial experiments, the analysis
was set to ∼24 h, ∼27 h, and ∼30 h post-transfection for Cdc42,
Rac1, and RhoA, respectively, by evaluating the time it took until the
cells expressed the proteins and adapted the expected morphologies.
The Flp-In T-Rex HeLa cells with inducible expression of GFP-
GRAF1 were seeded in 6 well plates (250 000 cells/well) 24 h prior to
induction. GFP-GRAF1 expression was induced by addition of 1 ng/
mL doxycycline hyclate, and 3 h postinduction the cells were
transfected with mCherry-tagged Cdc42 WT or DA Q61L by
Lipofectamine 2000 (0.5 μg of DNA and 1 μL of Lipofectamine/well)
following the protocol provided by the manufacturer. At 5 h post-
transfection, the cells were harvested and reseeded in glass-bottomed
dishes followed by Aβ exposure and imaging 24 h post-reseeding.
Confocal Microscopy. Confocal images were acquired on a
Nikon C2+ confocal microscope equipped with a C2-DUVB GaAsP
Detector Unit and using an oil-immersion 60× 1.4 Nikon APO
objective (Nikon Instruments, Amsterdam, The Netherlands). The
sample was excited and detected with appropriate excitation laser lines
and emission filters, sequentially for samples including fluorophores
excited at 488 nm, 561 nm, and 640 nm, or simultaneously using a
filter cube to split the channels when imaging only fluorophores
excited at 488 and 640 nm.
Flow Cytometry. Flow cytometry was used for quantification of
cellular uptake. Prior to analysis, the cells were washed 3×/2 min in
ice-cold serum free medium (Aβ(1-42) and dextran 10 kDa) or acidic
buffer (0.1 M glycine-HCl buffer pH 2.5 with 150 mM NaCl; Trf)
and detached by trypsin-EDTA 0.25% for 7 min followed by addition
of ice-cold FBS-supplemented cell culture medium to inhibit further
proteolytic degradation of the cells. All samples were kept on ice until
they were analyzed on a Guava EasyCyte 8HT (Millipore, Darmstadt,
Germany) that automatically retrieves samples from a 96-well plate. In
order to exclude effects due to difference in delay time, we used mixed
order of analysis, loading only a few samples at a time with the
remaining samples kept on ice. Only the central cell cluster on the
forward/side scatter (FSC/SSC) dot plot was analyzed, and for each
sample 5 000 cells from within the gate were counted. The EGFP,
HF488, and AF488 fluorophores were excited by a 488 nm laser, and
fluorescence was detected through a 525/30 nm filter. HF647 and
AF647 was excited with a 635 nm laser and detected through a 661/
19 nm filter. The mean cellular uptake or level of Rho GTPase
expression was estimated as the average fluorescence intensity of all
cells within the gate. The mean cellular uptake was baseline corrected
by subtracting the signal recorded for untreated cells. Each cell
treatment was performed in three or four technical replicates (n = 3−
4) and repeated on at least two separate occasions (N ≥ 2). All flow
cytometry data was analyzed in InCyte software (Millipore,
Darmstadt, Germany) and displayed using Origin software (Origin-
Lab, Northampton, MA).
Statistics. Statistical analysis was performed by matched sample
ANOVA using GraphPad Prism software (GraphPad, San Diego, CA)
on data that had been normalized so that the uptake in nontransfected
cells was 100% for the individual experiments. Matched sample
ANOVA was followed by multiple comparisons with the Bonferroni
posthoc test to test for differences in mean peptide uptake between
nontransfected cells and uptake at the different transfection
efficiencies. This means that the reported individual p-values have
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